MIRM - JP Morgan bullish on six Big Biotechs rates nine others neutral or lower
2023-11-25 16:32:53 ET
More on BioCryst Pharmaceuticals, Crinetics Pharmaceuticals, etc.
- Mirum Pharmaceuticals, Inc. (MIRM) Q3 2023 Earnings Call Transcript
- BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2023 Earnings Call Transcript
- Immunocore: First Half Of 2024 IMC-F106C Data Expected
- Mirum draws $60 target from Morgan Stanley on liver disease prospects
- BioCryst, Clearside Biomedical in pact for diabetic eye disease
For further details see:
JP Morgan bullish on six Big Biotechs, rates nine others neutral or lower